
BioVig-India Programme establishes a national framework for monitoring safety concerns associated with biological medical products. It aims to identify, assess and prevent adverse events involving vaccines, biological medicines and specified transplantation-related products.

Biosimilar Standards strengthen medicine quality, patient safety and access to advanced therapies. Read the full UPSC analysis by Chetan Bharat Learning.
Recent Posts
Related Tags